Mallory Morales
Vermögen: 113 711 $ am 31.07.2026
Vermögen: 113 711 $ am 31.07.2026
Mallory Morales is currently Chief Accounting Officer & Senior VP-Finance at Immuneering Corp.
since 2026, with employment at the firm starting in 2021.
Former positions include Director & Assistant Controller at Immunomedics, Inc. from 2018 to 2020, Director-Finance & Global Brand Controller at L'Oréal SA from 2014 to 2018, and Partner-Strategic Finance Business at Gilead Sciences, Inc. from 2020 to 2021.
Education includes undergraduate studies at the State University of New York at Albany.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.02.2026 | 27 533 ( 0,04 % ) | 113 711 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNEERING CORPORATION | Comptroller/Controller/Auditor | 10.08.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.05.2021 |
| IMMUNOMEDICS, INC. | Direktor/Vorstandsmitglied | 01.10.2020 |
| L'ORÉAL | Finanzdirektor/CFO | 01.04.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
L'Oréal SA
L'Oréal SA Household/Personal CareConsumer Non-Durables Manufactures and markets beauty and hair products | Consumer Non-Durables |
State University of New York at Albany
State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen